Skip to content

JNJ

JOHNSON & JOHNSON

NYSE · Healthcare · Drug Manufacturers - General · US

$266.32
+0.28%
Ask drillr
Price chart
Aug 13Aug 18Aug 21Aug 26Aug 31Sep 3Sep 9Sep 14
P/E (Fwd)
22.3x
EV/EBITDA
19.9x
Market Cap
$641.80B
RSI (14)
51.4
1D Return
+0.28%
YTD Return
+29.41%
SummaryUpdated Jun 1, 2026

Johnson & Johnson (NYSE:JNJ) is one of the world's largest and most diversified healthcare companies, founded in 1886 by the Johnson brothers in New Brunswick, New Jersey. Originally starting as a manufacturer of ready-to-use sterile surgical dressings, the company has evolved over nearly 140 years into a global healthcare conglomerate. Today, J&J operates as a two-sector company focused on <b>Innovative Medicine</b> (pharmaceuticals) and <b>MedTech</b> (medical devices), having completed the spin-off of its Consumer Health division (Kenvue) in 2023. The company serves patients, healthcare professionals, and consumers across more than 175 countries worldwide, maintaining its position as a healthcare industry leader through continuous innovation and strategic acquisitions.

Similar companies

Latest newsMore news →